Page 1528 - Small Animal Internal Medicine, 6th Edition
P. 1528

1500   PART XIV   Infectious Diseases


              (PMPDAP) in the treatment of feline immunodeficiency virus-  Nichols J, et al. Commercially available enzyme-linked immuno-
              infected cats. J Feline Med Surg. 2012;14:107.      sorbent assay and polymerase chain reaction tests for detection
  VetBooks.ir  Hartmann K, et al. AZT in the treatment of feline immunodefi-  Pedersen NC, et al. Isolation of a T-lymphotrophic virus from
                                                                  of feline immunodeficiency virus infection.  J Vet Intern Med.
            Hartmann K, et al. AZT in the treatment of feline immunodefi-
                                                                  2017;3:55.
              ciency virus infection I. Fel Pract. 1995a;23:16.
              ciency virus infection II. Fel Pract. 1995b;23:16.  domestic cats with an immunodeficiency-like syndrome. Science.
            Hartmann K. Clinical aspects of feline immunodeficiency and   1987;235:790.
              feline leukemia virus infection.  Vet Immunol Immunopathol.   Pedretti E, et al. Low-dose interferon-alpha treatment for feline
              2011;143:190.                                       immunodeficiency virus infection. Vet Immunol Immunopathol.
            Hartmann K, et al. Efficacy and adverse effects of the antiviral com-  2006;109:245.
              pound plerixafor in feline immunodeficiency virus-infected cats.   Power C. Neurologic disease in feline immunodeficiency virus
              J Vet Intern Med. 2012;26:483.                      infection: disease mechanisms and therapeutic interventions for
            Hartmann K, et al. Efficacy of antiviral drugs against feline immu-  NeuroAIDS. J Neurovirol. 2018;24:220.
              nodeficiency virus. Vet Sci. 2015;2:456.           Rolim VM, et al. Myocarditis caused by feline immunodeficiency
            Kann RK, et al. Association between feline immunodeficiency virus   virus in five cats with hypertrophic cardiomyopathy.  J Comp
              (FIV) plasma viral RNA load, concentration of acute phase pro-  Pathol. 2016;154:3.
              teins and disease severity. Vet J. 2014;201:181.   Sarvani E, et al. Prevalence and risk factor analysis for feline
            Kornya MR, et al. Association between oral health status and   haemoplasmas in cats from Northern Serbia, with molecular
              retrovirus test results in cats.  J Am Vet Med Assoc. 2014;245:   subtyping of feline immunodeficiency virus.  JFMS  Open  Rep.
              916.                                                2018;4:2055116918770037.
            Lappin MR, et al. Primary and secondary Toxoplasma gondii infec-  Sato R, et al. Oral administration of bovine lactoferrin for treatment
              tion in normal and feline immunodeficiency virus-infected cats.   of intractable stomatitis in feline immunodeficiency virus (FIV)-
              J Parasitol. 1996;82:733.                           positive and FIV-negative cats. Am J Vet Res. 1996;57:1443.
            Leal RO, et al. Evaluation of viremia, proviral load and cytokine   Spada E, et al. Survival time and effect of selected predictor vari-
              profile in naturally feline immunodeficiency virus infected cats   ables on survival in owned pet cats seropositive for feline immu-
              treated with two different protocols of recombinant feline inter-  nodeficiency and leukemia virus attending a referral clinic in
              feron omega. Res Vet Sci. 2015;99:87.               northern Italy. Prev Vet Med. 2018;150:38.
            Leal RO, Gil S. The use of recombinant feline interferon omega   Taffin ER, et al. Systolic blood pressure, routine kidney variables and
              therapy as an immune-modulator in cats naturally infected   renal ultrasonographic findings in cats naturally infected with
              with feline immunodeficiency virus: new perspectives. Vet Sci.   feline immunodeficiency virus. J Feline Med Surg. 2017;19:672.
              2016;3:E32. doi:10.3390/vetsci3040032.             Tasker S, et al. Effect of chronic FIV infection, and efficacy of mar-
            Levy J, et al. 2008 American Association of Feline Practition-  bofloxacin treatment, on Mycoplasma haemofelis infection. Vet
              ers’ feline retrovirus management guidelines.  J Fel Med Surg.   Microbiol. 2006a;117:169.
              2008;10:300.                                       Tasker S, et al. Effect of chronic feline immunodeficiency infection,
            Levy JK, et al. Effect of vaccination against feline immunodefi-  and efficacy of marbofloxacin treatment, on “Candidatus Myco-
              ciency virus on results of serologic testing in cats. J Am Vet Med   plasma haemominutum” infection.  Microbes Infect. 2006b;8:
              Assoc. 2004;225:1558.                               653.
            Levy  JK,  et al.  Seroprevalence  of  feline  leukemia  virus  and   Titmarsh HF, et al. Vitamin D status in cats with feline immuno-
              feline  immunodeficiency virus infection among cats in North   deficiency virus. Vet Med Sci. 2015;1:72.
              America and risk factors for seropositivity. J Am Vet Med Assoc.   Weese JS, et al. The rectal microbiota of cats infected with feline
              2006;228:371.                                       immunodeficiency virus infection and uninfected controls. Vet
            Levy JK, et al. Performance of 4 point-of-care screening tests for   Microbiol. 2015a;180:96.
              feline leukemia virus and feline immunodeficiency virus. J Vet   Weese SJ, et al. The oral and conjunctival microbiotas in cats with
              Intern Med. 2017;31:521.                            and without feline immunodeficiency virus infection.  Vet  Res.
            Liem BP, et al. Clinical findings and survival in cats naturally   2015b;46:21.
              infected with feline immunodeficiency virus. J Vet Intern Med.   Westman ME, et al. Duration of antibody response following vacci-
              2013;27:798.                                        nation against feline immunodeficiency virus. J Feline Med Surg.
            Litster  AL.  Transmission  of  feline  immunodeficiency  virus   2017;19:1055.
              (FIV) among cohabiting cats in two cat rescue shelters.  Vet J.   Westman  ME,  et al.  Diagnosing  feline  immunodeficiency  virus
              2014;201:184.                                       (FIV) infection in FIV-vaccinated and FIV-unvaccinated cats
            Magden E, et al. FIV associated neoplasms—a mini-review.  Vet   using saliva. Comp Immunol Microbiol Infect Dis. 2016a;46:66.
              Immunol Immunopathol. 2011;143:227.                Westman ME, et al. The protective rate of the feline immuno-
            McLuckie AJ, et al.  Felis catus gammaherpesvirus 1 DNAemia   deficiency virus vaccine: an Australian field study.  Vaccine.
              in whole blood from therapeutically immunosuppressed or   2016b;34:4752.
              retrovirus-infected cats. Vet Sci. 2017;14:4.
            Miller C, et al. Pathogenesis of oral FIV infection.  PLoS ONE.   Feline Leukemia Virus
              2017;12:e0185138.                                  Addie DD, et al. Long-term impact on a closed household of pet
            Mohammadi H, Bienzle D. Pharmacological inhibition of feline   cats of natural infection with feline coronavirus, feline leukaemia
              immunodeficiency virus (FIV). Viruses. 2012;4:708.  virus and feline immunodeficiency virus. Vet Rec. 2000;146:419.
            Murphy BG, et al. Multiple, independent T cell lymphomas arising   Cattori V, et al. The kinetics of feline leukaemia virus shedding
              in an experimentally FIV-infected cat during the terminal stage   in experimentally infected cats are associated with infection
              of infection. Viruses. 2018;24:10.                  outcome. Vet Microbiol. 2009;133:292.
   1523   1524   1525   1526   1527   1528   1529   1530   1531   1532   1533